Cartalax is a synthetic short-chain peptide commonly described as Ala-Glu-Asp (AED). It is classified as a peptide bioregulator and has primarily been studied in relation to cartilage, connective tissue, and cellular processes. Cartalax is a small tripeptide investigated for its potential biological effects on cartilage and connective-tissue-related processes. Current research is primarily preclinical, and its mechanisms and potential applications continue to be investigated.